Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Peptide Process CMCPeptide Process CMC
Not Confirmed
Not Confirmed
28-30 August, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Peptide Process CMCPeptide Process CMC
Industry Trade Show
Not Confirmed
28-30 August, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
25 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-to-present-detailed-positive-results-from-vibrance-1-phase-2-study-evaluating-alixorexton-in-patients-with-narcolepsy-type-1-at-world-sleep-2025-302537255.html
29 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-plc-reports-second-quarter-2025-financial-results-302515286.html
21 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-announces-positive-topline-results-from-vibrance-1-phase-2-study-of-once-daily-alixorexton-in-patients-with-narcolepsy-type-1-302509211.html
21 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/alkermes-reports-phase-2-narcolepsy-win-advancing-challenger-takedas-blockbuster-dream
15 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-to-report-second-quarter-financial-results-on-july-29-2025-302505916.html
02 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-46th-annual-goldman-sachs-global-healthcare-conference-302471011.html
Excipients
Inspections and registrations
ABOUT THIS PAGE
Alkermes Plc is a supplier offers 12 products (APIs, Excipients or Intermediates).
Find a price of Sirolimus bulk with DMF, JDMF offered by Alkermes Plc
Find a price of Dead On Polystyrene bulk with DMF offered by Alkermes Plc
Find a price of Dimethyl Sulfoxide bulk with DMF offered by Alkermes Plc
Find a price of Dl-Threo-3,4-Dihydroxyphenylserine bulk offered by Alkermes Plc
Find a price of Fluvoxamine bulk offered by Alkermes Plc
Find a price of Meloxicam bulk offered by Alkermes Plc
Find a price of Morphine Sulfate bulk offered by Alkermes Plc
Find a price of N1714 TABLETS bulk offered by Alkermes Plc
Find a price of PROLEASE DILUENT USED FOR SUSPENSION OF PROLEASE MICROSPHERE PRODUCTS FOR PRODUCT ADMINISTRATION bulk offered by Alkermes Plc
Find a price of N1679 NANOCRYSTAL CAPSULE bulk offered by Alkermes Plc
Find a price of N1752 EXTENDED RELEASE TABLETS, 18MG bulk offered by Alkermes Plc
Find a price of ELND-005 bulk offered by Alkermes Plc